Enzon Pharmaceuticals buy DomRuinart
Start price
01.12.20
/
50%
€0.12
Target price
01.12.21
€0.000
Performance (%)
49.17%
End price
14.12.20
€0.18
Summary
This prediction ended on 14.12.20 with a price of €0.18. With a performance of 49.17% the BUY prediction by DomRuinart was a big success. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enzon Pharmaceuticals | 0.000% | 0.000% | -19.492% | -66.312% |
| iShares Core DAX® | 1.518% | 3.456% | 25.970% | 21.597% |
| iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% | 39.177% |
| iShares Nikkei 225® | 2.808% | 2.743% | 19.597% | 5.115% |
| iShares S&P 500 | 0.403% | 2.187% | 28.624% | 40.348% |
According to DomRuinart what are the pros and cons of Enzon Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Enzon Pharmaceuticals diskutieren
Buy mit Kursziel 0,0